LTI-01

N/A

Report date: 2025/01/23 15:52:41
First In Class

Base Information

Drug NameLTI-01
Drug Alias NameSingle Chain UrokinasescuPA (Lung Therapeutics)LTI-01
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionPlasminogen activators inhibitors
TargetsPlasminogen activators
Therapy Area/IndicationsPleural Effusion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLung Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaiho Pharmaceutical Co LtdRein Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPleural Effusion
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A